Pharma Invest Devos SPRL
0.1 FTEThe score of Pharma Invest Devos shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets +13 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Invest Devos's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 05 Jan 2026
- Year ended 30 Jun 2024filed on 06 Jan 2025
- Year ended 30 Jun 2023filed on 05 Jan 2024
- Year ended 30 Jun 2022filed on 04 Jan 2023
- Year ended 30 Jun 2021filed on 05 Jan 2022
Pharma Invest Devos's financial analysis
- Solvency75.2%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Invest Devos
Pharma Invest Devos's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0899.883.252
- VAT number
- BE0899883252
- Peppol
- Registered · 0208:0899883252 · as of 09 Nov 2026
- Legal form
- SPRL
- Incorporated
- 20 Aug 2008
- Registered office
- 1501 Halle
- Size
- Micro · 0.1 FTE
- Latest accounts
- 2025 · filed on 05 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma Invest Devos (SPRL) has been based in Halle since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 61,887 € and equity of 618,231 €; its revenue is not published. With 0.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 75.2%, above the median of its sector (44.0%).
Companies similar to Pharma Invest Devos
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Anciaux Retail sale of pharmaceutical products Woluwe-Saint-Pierre · balance sheet 823,388 €
- Verkest - Lesage Retail sale of pharmaceutical products Roeselare · balance sheet 845,357 €
- Apotheek Baensland Retail sale of pharmaceutical products Sint-Niklaas · balance sheet 866,828 €
- PhilClapharma Retail sale of pharmaceutical products Tervuren · balance sheet 867,932 €
- Pharmidable Retail sale of pharmaceutical products Namur · balance sheet 775,771 €
- Geassocieerde Apotheek VAN Puyvelde Retail sale of pharmaceutical products Antwerp · balance sheet 908,969 €
- Cosom Retail sale of pharmaceutical products Genappe · balance sheet 931,343 €
Frequently asked questions about Pharma Invest Devos
What is the revenue of Pharma Invest Devos?
Pharma Invest Devos files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Invest Devos?
In Belgium, the VAT number is the company number prefixed with BE: BE0899883252 for Pharma Invest Devos, if the company is VAT-registered. Its company number (CBE) is 0899.883.252.
Where is the registered office of Pharma Invest Devos?
According to the CBE register, the registered office of Pharma Invest Devos is in 1501 Halle.
What is the equity of Pharma Invest Devos?
At the close of the 2025 financial year, the equity of Pharma Invest Devos amounts to 618,231 €, a solvency of 75.2% of total assets.
How many people work at Pharma Invest Devos?
0.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharma Invest Devos?
The register lists 1 active mandates at Pharma Invest Devos. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Invest Devos
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →